Abacavir+Lamivudine 600mg+300mg Suppliers & Bulk Manufacturers
Available Forms: Tablets / Oral solution
Available Strengths: 600mg+300mg
Reference Brands: Epzicom (USA), Kivexa(USA/EU), Ziagen (USA/EU)
Category: Anti Viral
Abacavir/Lamivudine is a fixed-dose antiretroviral combination used in the treatment of HIV-1 infection. It combines two nucleoside reverse transcriptase inhibitors (NRTIs) that work by inhibiting the reverse transcriptase enzyme, preventing viral replication and reducing viral load in patients.
Abacavir+Lamivudine — third party manufacturing & bulk supply
Abacavir+Lamivudine 600mg+300mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Abacavir+Lamivudine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Abacavir+Lamivudine →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Abacavir and Lamivudine are used together as part of combination antiretroviral therapy for the treatment of HIV-1 infection. This fixed-dose combination helps lower viral load, improve immune function, and reduce the progression of HIV when used with other antiretroviral medicines.
This combination contains two active ingredients: abacavir, a nucleoside reverse transcriptase inhibitor (NRTI) that blocks viral DNA chain elongation, and lamivudine, another NRTI that interferes with viral replication by inhibiting reverse transcriptase. Together, they provide dual NRTI backbone coverage.
The most recognized international trade names for this combination are Kivexa and Epzicom. Several generic brands also exist in different markets.
Kivexa and Epzicom are manufactured by ViiV Healthcare, a joint venture of GSK, Pfizer, and Shionogi.
The generic name of the product is abacavir and lamivudine.
Common brand names include Kivexa and Epzicom, along with various generic versions depending on the region.
Abacavir and Lamivudine combination products (Kivexa/Epzicom) are manufactured by ViiV Healthcare in its approved global facilities. Generic formulations are widely produced in India and other countries by licensed pharmaceutical manufacturers based on regulatory approvals.
Related Products
Brincidofovir
Strength:
100 mg, 10 mg/ml
Form: Tablets / Oral suspension
Reference Brands: Tembexa (USA/EU)
View Details
Lenacapavir
Strength:
300 mg, 463.5 mg/1.5 mL
Form: Tablet / Injection
Reference Brands: Yeztugo (USA), Sunlenca (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
